Why the study?
Cardiolipotoxicity results from lipid accumulation in cardiac myocytes, but has no definite cause or treatment yet identified.
Population
A 69-year-old gentleman with heart failure and ventricular tachycardia
Design
Case report and literature review
Authors
Loading...
Highlights cardiolipotoxicity in HF with VT; leaves open whether targeting lipid metabolism alters outcomes.
This case highlights a rare instance of cardiolipotoxicity identified via endomyocardial biopsy in a patient with heart failure and ventricular tachycardia.
Gupta et al. (2020) studied this question.